Development and Manufacturing Agreement Partnership for Development of Anti-HIV and Anti-SARS-CoV-2 Therapies
Editor: Alexander Stark
Samsung Biologics and Enzolytics announced the signing of a strategic CDMO partnership agreement for the development and manufacturing of Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibody Therapies.
Samsung Biologics is a fully integrated CDMO.
(Source: Samsung Biologics)
College Station/USA; Incheon/South Korea — Under the terms of an agreement between Samsung Biologics and Enzolytics, the South Korean company will provide end-to-end CDMO services from cell line development, clinical drug substance, and drug product manufacturing services to support IND filings for Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibodies for the treatment of HIV and SARS-CoV-2. In addition, there will be continuing discussions for other Monoclonal Antibodies being developed by Enzolytics.
The Enzolytics protocol offers the opportunity to implement AI analysis and provides a platform for creating multiple fully human Monoclonal Antibodies targeting conserved immutable sites on the virus and offering a cure for these viruses. A stable cell line will be manufactured with support from Samsung Biologics' R&D Center in San Francisco. Its related clinical trial materials will be manufactured at Samsung Biologics headquarters in Incheon, South Korea.
Unfold for details of your consent
Stand vom 23.03.2021
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://support.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.
:quality(80)/p7i.vogel.de/wcms/d5/27/d52718f1b5c0c1326836ec98a3912dbf/0104995823.jpeg "0104995823")
:quality(80)/p7i.vogel.de/wcms/e0/c8/e0c8f10f52ed8e961d2b1929175cbb96/0104994911.jpeg "0104994911")
:quality(80)/p7i.vogel.de/wcms/16/af/16af797a8a1f8bb82362dfa476acb996/0104964405.jpeg "0104964405")
:quality(80)/p7i.vogel.de/wcms/c0/34/c034428f6f7de33dbc90e8b1fdc7fb21/0104949732.jpeg "0104949732")
:quality(80)/p7i.vogel.de/wcms/d9/4b/d94b9122c3c0cb11915ca1e116bea997/0104986115.jpeg "0104986115")
![Dr. E. Poonguzhali has successfully transferred commercially available starting materials to medicinally important 2-acylbenzo[b]thiophenes in the presence of copper acetate & tetrabutylammonium chloride catalytic system.](https://cdn1.vogel.de/ZK7wqjVy7Ps1OSwUs5tXgrNZGEE=/288x162/smart/filters:format(jpg):quality(80)/images.vogel.de/vogelonline/bdb/1964500/1964559/original.jpg "Dr. E. Poonguzhali has successfully transferred commercially available starting materials to medicinally important 2-acylbenzo[b]thiophenes in the presence of copper acetate & tetrabutylammonium chloride catalytic system.")
:quality(80)/images.vogel.de/vogelonline/bdb/1963700/1963740/original.jpg "The high resolution, modern TFT touch display has a multi-lingual user interface and shows all important information at a glance.")
:quality(80)/images.vogel.de/vogelonline/bdb/1963400/1963417/original.jpg "The 700kHz, 260-element histotripsy ultrasound array transducer used in Prof. Xu’s lab.")
:quality(80)/images.vogel.de/vogelonline/bdb/1963800/1963885/original.jpg "Anna-Lisa Paul, left, and Rob Ferl, working with lunar soils in their lab.")
:quality(80)/images.vogel.de/vogelonline/bdb/1962400/1962494/original.jpg "The operating room produces 70 percent of hospitals' greenhouse gas emissions, but two surgeons-in-training have come up with solutions to reduce that number.")
:quality(80)/images.vogel.de/vogelonline/bdb/1960700/1960778/original.jpg "This plant is modeling the latest wearable sensor (right) to monitor water loss from leaves with a smartphone app (left).")
:quality(80)/images.vogel.de/vogelonline/bdb/1958800/1958848/original.jpg "The user-friendly unit, which weighs less than ten kilograms and does not require the use of filters, can be powered by a small, portable solar panel.")
:quality(80)/p7i.vogel.de/wcms/0d/3b/0d3b418adb4c7af71022c52878dd8fdf/0104800005.jpeg "0104800005")
:quality(80)/images.vogel.de/vogelonline/bdb/1963700/1963732/original.jpg)
:quality(80)/images.vogel.de/vogelonline/bdb/1963500/1963506/original.jpg "Healthy adults eating a diverse diet with at least eight to ten grams of soluble fiber a day have fewer antibiotic-resistant microbes in their guts. Soluble fiber is found in foods such as grains, beans, lentils, nuts, and some fruits and vegetables.")
:quality(80)/images.vogel.de/vogelonline/bdb/1963400/1963459/original.jpg "Thermo Scientific Dionex Ionpac CS21-Fast-4m ion exchange column.")
:quality(80)/p7i.vogel.de/wcms/2a/d9/2ad9f27ac42afb15a06350c4c5fb17c9/0104994092.jpeg "0104994092")
:quality(80)/p7i.vogel.de/wcms/29/a8/29a87518fdfa5741b9cf4429a448729f/0104917902.jpeg "0104917902")
:quality(80)/p7i.vogel.de/wcms/93/1b/931ba9a54f6fff41d2cdd7cf74a1e174/0104884529.jpeg "0104884529")
:quality(80)/p7i.vogel.de/wcms/b7/3c/b73c41e85851adc1e2be52f7eefa194f/0104868646.jpeg "0104868646")
:quality(80)/images.vogel.de/vogelonline/bdb/1710600/1710675/original.jpg "Discover how to set yourself up for success when performing balance-based density determination of solids such as jewelry and precious metals.")
:quality(80)/images.vogel.de/vogelonline/bdb/1682500/1682579/original.jpg "The new XPR Analytical balance redesigned to meet the needs of laboratory technicians of working fast and lean.")
:quality(80)/images.vogel.de/vogelonline/bdb/1677000/1677080/original.jpg "Enhance your weighing accuracy, comfort and productivity with the redesigned XPR Analytical balance.")
:quality(80)/images.vogel.de/vogelonline/bdb/1890200/1890291/original.jpg "To better understand the genetic architecture of host proteins interacting with SARS-CoV-2 or mediating host response to COVID-19 - using an aptamer-based technique can help to identify new or repurpose existing drugs targeting those proteins.")
:quality(80)/images.vogel.de/vogelonline/bdb/1911000/1911007/original.jpg "Lonza and Bioqube Ventures signed a framework agreement for the future development and manufacture of biologics and small molecules for Bioqube’s portfolio companies.")